Cite
HARVARD Citation
Bergqvist, M. et al. (2020). Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010–2016 in Sweden: A nationwide observational study. International journal of cancer. 146 (9), pp. 2510-2517. [Online].